Renal failure after intravesical mitomycin C.
Severe side effects, local or systemic, are uncommon with intravesically administered mitomycin C. Bladder fibrosis and contracture, with resultant renal failure, are unusual but possible.
Farha
A J
AJ
Veterans Administration Medical Center, Syracuse, New York.
Krauss
D J
DJ
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000283:Administration, Intravesical; D002278:Carcinoma in Situ / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D008937:Mitomycins; D016685:Mitomycin